Steglatro

Ummm....< 1% market share for Stelagasaurus in my territory

 

I understand that it is less than 1% in some territories but in others it is approaching 15. The overall share nationally is about 10

 

Total BS. No it’s not. It is not even 1% Nationally.

 

Look at the latest Gator!!! Nationally Steglatro is showing its teeth. 10 % national share. What a launch. You live obviously with how well you come out of the gate. And Steglatro set the standard on how to make a drug a leader in the market. Great job

 

Yes! Our management did a great job with the launch, setting the strategy for us to be successful!

 

We have a 42.83% market share in my territory!

 

That is amazing to have captured that much of the market in such a short time when an earlierpollster said the company is at 1% share. Which is it ?

 

Most people have greater than a 20 share with Steglatro. This has been one of the most successful launches in Merck history or for that matter the whole industry

 

I concur. This Steglatro is the best drug Merck has ever had and the market share is proving it. Hail a great drug!

 

Also hail to my mother for blowing every brown rep at the club.

 

Was there any mention of Steglatro on the earnings call? Steglatro has become the flagship product of Merck. Shares and revenue are soaring. What a drug that is making a big difference in many people ‘s lives

 

Steglatro was mentioned right after Keytruda which really puts emphasis of how great the drug is doing and the impact Steglatro is making in the diabetes es market. What a great drug and now the investment community realizes how great Steglatro is. Congratulations Steglatro and the entire Steglatro sales force

 

Yes. All of it is true. But, when Januvia goes generic and when Novo’s new drug comes out, off with the head!

 

Why has Steglatro been so successful

 

Look at the latest Gator with Steglatro. It is simply killing it. Jardiance is having special meetings across the country to discuss this drug

 

Boeringer finished a 2 day meeting focusing exclusively on how well Steglatro is doing. They are seeing their market share dissolve because of Steglatro and they are worried

 

left

 

steglatro is doing so well that we won't even be selling it by 2021